Acute Extrapyramidal Symptoms
Short placeholder sentence on acute dystonia and parkinsonism.
- Hours–weeks: Onset window (Placeholder short caption)
- Dystonia: Common signs (Placeholder short caption)
- D2 blockade: Mechanism (Placeholder short caption)
- Higher/Lower: Typical vs atypical (Placeholder short caption)
Acute reaction mechanisms
Placeholder short paragraph on acute EPS mechanisms and presentation.
Chronic Dopamine Receptor Supersensitivity
Short placeholder sentence on D2 receptor upregulation over years.
- D2 upregulation: Receptor change (Placeholder short caption)
- Months–years: Timeframe (Placeholder short caption)
- Chronic blockade: Driver (Placeholder short caption)
- Supersensitivity: Outcome (Placeholder short caption)
Supersensitivity hypothesis
Placeholder short paragraph on receptor supersensitivity theory.
Tardive Dyskinesia Onset
Short placeholder sentence on lip smacking and tongue protrusion onset.
- Orofacial: Hallmark signs (Placeholder short caption)
- ~Years-linked: Cumulative risk (Placeholder short caption)
- Higher risk: Typical drugs (Placeholder short caption)
- Lower risk: Atypical drugs (Placeholder short caption)
Movement pattern development
Placeholder short paragraph describing progressive movement patterns.
AIMS Scale Assessment
Short placeholder sentence on the Abnormal Involuntary Movement Scale.
- 0–40: Scale range (Placeholder short caption)
- Face/limb/trunk: Domains scored (Placeholder short caption)
- Every 3–6mo: Screening interval (Placeholder short caption)
- Track severity: Purpose (Placeholder short caption)
AIMS scoring approach
Placeholder short paragraph on AIMS scoring procedure.
Typical vs Atypical Antipsychotic Comparison
Short placeholder sentence comparing long-term EPS/TD burden by drug class.
- ~5%: Typical TD/yr (Placeholder short caption)
- ~1%: Atypical TD/yr (Placeholder short caption)
- Declines w/ time: Reversibility (Placeholder short caption)
- Lower dose/switch: Clinical takeaway (Placeholder short caption)
Comparative long-term risk
Placeholder short paragraph comparing drug classes over time.
Placeholder short key-insight sentence on minimizing cumulative TD risk.